Indeed, several in vitro studies have shown that cancer cells shed EVs containing procoagulant TF [6, 7] and clinical studies have suggested that TF-containing EVs are associated with and may cause thrombosis in cancer patients [8, 9], but this view is disputed by others [7, 10]. The gene discussed is TF; the disease is cancer.